159 related articles for article (PubMed ID: 7556150)
21. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies.
Oda Y; Sanders J; Evans M; Kiddie A; Munkley A; James C; Richards T; Wills J; Furmaniak J; Smith BR
Thyroid; 2000 Dec; 10(12):1051-9. PubMed ID: 11201849
[TBL] [Abstract][Full Text] [Related]
22. The gene expression of coagulation factor VIII in mammalian cell lines.
Chen C; Fang XD; Zhu J; Wu XF; Zhang ZC; Gu JX; Wang ZY; Chi CW
Thromb Res; 1999 Jul; 95(2):105-15. PubMed ID: 10418799
[TBL] [Abstract][Full Text] [Related]
23. A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.
Marquette KA; Pittman DD; Kaufman RJ
J Biol Chem; 1995 Apr; 270(17):10297-303. PubMed ID: 7730335
[TBL] [Abstract][Full Text] [Related]
24. Characterization, molecular cloning and expression of megakaryocyte potentiating factor.
Yamaguchi N; Yamamura Y; Konishi E; Ueda K; Kojima T; Hattori K; Oheda M; Imai N; Taniguchi Y; Tamura M; Ochi N
Stem Cells; 1996; 14 Suppl 1():62-74. PubMed ID: 11012204
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.
Kaufman RJ; Wasley LC; Dorner AJ
J Biol Chem; 1988 May; 263(13):6352-62. PubMed ID: 3129422
[TBL] [Abstract][Full Text] [Related]
26. Post-translational requirements for functional factor V and factor VIII secretion in mammalian cells.
Pittman DD; Tomkinson KN; Kaufman RJ
J Biol Chem; 1994 Jun; 269(25):17329-37. PubMed ID: 8006042
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of a new recombinant factor VIII (N8).
Thim L; Vandahl B; Karlsson J; Klausen NK; Pedersen J; Krogh TN; Kjalke M; Petersen JM; Johnsen LB; Bolt G; Nørby PL; Steenstrup TD
Haemophilia; 2010 Mar; 16(2):349-59. PubMed ID: 19906157
[TBL] [Abstract][Full Text] [Related]
28. Mapping and partial characterization of proteases expressed by a CHO production cell line.
Sandberg H; Lütkemeyer D; Kuprin S; Wrangel M; Almstedt A; Persson P; Ek V; Mikaelsson M
Biotechnol Bioeng; 2006 Dec; 95(5):961-71. PubMed ID: 16897737
[TBL] [Abstract][Full Text] [Related]
29. B-Domain deleted recombinant coagulation factor VIII modified with monomethoxy polyethylene glycol.
Röstin J; Smeds AL; Akerblom E
Bioconjug Chem; 2000; 11(3):387-96. PubMed ID: 10821655
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
[TBL] [Abstract][Full Text] [Related]
31. Amino acid sequence and carbohydrate structure of a recombinant human tissue factor pathway inhibitor expressed in Chinese hamster ovary cells: one N-and two O-linked carbohydrate chains are located between Kunitz domains 2 and 3 and one N-linked carbohydrate chain is in Kunitz domain 2.
Nakahara Y; Miyata T; Hamuro T; Funatsu A; Miyagi M; Tsunasawa S; Kato H
Biochemistry; 1996 May; 35(20):6450-9. PubMed ID: 8639592
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of biologically active deletion mutants of human factor VIII:C.
Langner KD; Bird RE; McCandliss R; Huber B; Amann E; Zettlmeissl G; Küpper HA
Behring Inst Mitt; 1988 Apr; (82):16-25. PubMed ID: 3136764
[TBL] [Abstract][Full Text] [Related]
33. High level expression of recombinant porcine coagulation factor VIII.
Doering CB; Healey JF; Parker ET; Barrow RT; Lollar P
J Biol Chem; 2002 Oct; 277(41):38345-9. PubMed ID: 12138172
[TBL] [Abstract][Full Text] [Related]
34. Expression and characterization of a mutant recombinant blood coagulation factor VIII (rFVIII (m)).
Oh SH; Cho SY; Jin HS; Jeong DL; Jung SG; Oh KH
Exp Mol Med; 2002 Jul; 34(3):233-8. PubMed ID: 12216115
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of recombinant blood coagulation factor VIII (FVIII) heavy and light chains and reconstitution of active form of FVIII.
Oh SH; Lee MY; Song DW
Exp Mol Med; 1999 Jun; 31(2):95-100. PubMed ID: 10410309
[TBL] [Abstract][Full Text] [Related]
36. Expression of biologically active human factor VIII using a baculovirus vector.
Webb E; Tkalcevic J; Edwards S; Hocking D; Nisbet I
Biochem Biophys Res Commun; 1993 Jan; 190(2):536-43. PubMed ID: 8427596
[TBL] [Abstract][Full Text] [Related]
37. Molecular design and downstream processing of turoctocog alfa (NovoEight), a B-domain truncated factor VIII molecule.
Ahmadian H; Hansen EB; Faber JH; Sejergaard L; Karlsson J; Bolt G; Hansen JJ; Thim L
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):568-75. PubMed ID: 26761578
[TBL] [Abstract][Full Text] [Related]
38. Perspectives on progressive strategies and recent trends in the production of recombinant human factor VIII.
Mannully ST; L N R; Pulicherla KK
Int J Biol Macromol; 2018 Nov; 119():496-504. PubMed ID: 30063930
[TBL] [Abstract][Full Text] [Related]
39. Stable expression of native Coagulation factor VIII using the 2A self-processing sequence and furin cleavage site.
He B; Pan Y; Chen L; Xu Y; Chen N; Gu L; Nie Z; Wang S; Liu Z
Thromb Res; 2011 Dec; 128(6):e148-53. PubMed ID: 21803400
[TBL] [Abstract][Full Text] [Related]
40. Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients.
Fijnvandraat K; Berntorp E; ten Cate JW; Johnsson H; Peters M; Savidge G; Tengborn L; Spira J; Stahl C
Thromb Haemost; 1997 Feb; 77(2):298-302. PubMed ID: 9157585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
